Many patients with IBD report persisting symptoms, despite resolution of the inflammatory process. Although by definition, a ...

Nanoparticles that turn inflammation into propulsion power deliver targeted IBD treatment, enhancing precision and efficacy.

Dow Jones futures were little changed after hours, along with S&P 500 futures and Nasdaq futures.The stock market rally was ...

Bhubaneswar: Smruti Swarup Patra, known by his stage name ‘Nextion’, has emerged as the first runner-up in the ‘Ultimate ...

The stock’s IBD Rating of 32 out of 99 indicates underperformance compared to most stocks over the past year. Despite the ...

Direct costs associated with IBD include ambulatory visits to gastroenterologists, emergency department visits, admissions ...

Fiber contains prebiotics that feed your good gut bacteria, promoting a healthy gut microbiome. A high-fiber diet may also ...

A randomized controlled trial finds no clear benefit of adding bezlotoxumab to FMT in patients with IBD and recurrent C difficile infection.

A rising RS line means that a stock is outperforming the S&P 500 index. IBD named Nu as Stock Of The Day on Oct. 28. Warren ...

Millions of Malaysians aren’t aware that a huge list of health problems —both mental and physical — can be directly linked to the state of their gut health.

The firm said they posted better-than-expected initial data from SPY001 and thinks the data incrementally de-risks its lead asset and broad pipeline, which could offer best-in-class dosing and ...

Aeglea Biotherapeutics Inc. ( (SYRE) ) has released its Q3 earnings. Here is a breakdown of the information Aeglea Biotherapeutics Inc.